Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Problem-solving skills deficit describes a cognitive impairment characterized by a reduced ability to identify problems, generate alternative solutions, make effective decisions, and implement or evaluate problem resolution strategies. This deficit is considered a manifestation of impaired executive function, a domain involving planning, flexibility, inhibition, and working memory, and is implicated in a range of psychiatric and neurological conditions, including ADHD, major depressive disorder, suicidality, traumatic brain injury (TBI), and neurodegenerative diseases. It is not a therapeutic target in the classical sense (such as a receptor or enzyme), but rather a neuropsychological symptom or syndrome often measured via behavioral tasks or clinical assessment tools. Interventions are typically behavioral (such as cognitive remediation, problem-solving therapy), occasionally pharmacological (indirectly, by treating the underlying disorder), and educational.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Problem-solving skills deficit.